RecruitingNCT07029256

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Jul 26, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether ultrasound-guided needle biopsy of the bladder (done just before the bladder is removed) can accurately determine how far bladder cancer has spread, which helps doctors plan surgery and further treatment. **You may be eligible if:** - You are scheduled to have your bladder removed (radical cystectomy) for confirmed or suspected bladder cancer - You have had prior abdominal imaging (such as CT scan) **You may NOT be eligible if:** - You have previously had a partial bladder removal or complex bladder reconstruction surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07029256


Related Trials